Table 6.
Multivariate analysis for variables associated with Major Bleeding.
| Variable | OR | 95% CI | P-value |
|---|---|---|---|
| Age | |||
| <60 | Ref | ||
| 60–79 | 1.42 | 0.41–4.89 | 0.58 |
| 80+ | 1.44 | 0.31–6.71 | 0.64 |
| Male gender | 0.73 | 0.26–2.04 | 0.55 |
| Cardioembolic etiology | 1.36 | 0.36–5.09 | 0.65 |
| NIHSS | |||
| 4–7 | Ref | ||
| 8+ | 1.84 | 0.59–5.76 | 0.30 |
| Past medical history | |||
| Atrial fibrillation | 1.99 | 0.41–9.62 | 0.39 |
| End stage liver disease | 6.73 | 0.63–71.78 | 0.12 |
| Prior hemorrhagic transformation | 2.95 | 0.76–11.50 | 0.12 |
| tPA or thrombectomy | 1.63 | 0.56–4.72 | 0.37 |
| DAPT at time of bleed | 0.34 | 0.08–1.50 | 0.15 |
Ref, Reference; tPA, tissue plasminogen activator; DAPT, dual antiplatelet therapy.